Paper41377008
Fractional exhaled nitric oxide (FeNO) in chronic obstructive respiratory diseases is associated with the bronchodilator response.
Nguyen TC and 5 others. J Thorac Dis, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Fractional exhaled nitric oxide (FeNO) in chronic obstructive respiratory diseases is associated with the bronchodilator response. Papers, record 41377008. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41377008
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fractional exhaled nitric oxide (FeNO) in chronic obstructive respiratory diseases is associated with the bronchodilator response.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29506620 | Allergen sensitisation among chronic respiratory diseases in urban and rural areas of the south of Viet Nam. | Int J Tuberc Lung Dis | 2018 | https://conductscience.org/library/papers/29506620 | PubMed |
| 2 | 29808101 | Clinical and Functional Characteristics of Subjects with Asthma, COPD, and Asthma-COPD Overlap: A Multicentre Study in Vietnam. | Can Respir J | 2018 | https://conductscience.org/library/papers/29808101 | PubMed |
| 3 | 32116037 | Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD. | COPD | 2020 | https://conductscience.org/library/papers/32116037 | PubMed |
| 4 | 36040171 | Asthma inflammatory phenotypes on four continents: most asthma is non-eosinophilic. | Int J Epidemiol | 2023 | https://conductscience.org/library/papers/36040171 | PubMed |
| 5 | 36968856 | The Correlation Between Fractional Exhaled Nitric Oxide (FeNO), Blood Eosinophil Count, Immunoglobulin E Levels, and Spirometric Values in Patients With Asthma. | Cureus | 2023 | https://conductscience.org/library/papers/36968856 | PubMed |
| 6 | 32377282 | Combination of Fractional Exhaled Nitric Oxide (FeNO) Level and Asthma Control Test (ATC) in Detecting GINA-Defined Asthma Control in Treated Asthmatic Patients in Vietnam. | Can Respir J | 2020 | https://conductscience.org/library/papers/32377282 | PubMed |
| 7 | 33708363 | Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review. | Eur Clin Respir J | 2021 | https://conductscience.org/library/papers/33708363 | PubMed |
| 8 | 24977053 | Subjects in a Population Study with High Levels of FENO Have Associated Eosinophil Airway Inflammation. | ISRN Allergy | 2011 | https://conductscience.org/library/papers/24977053 | PubMed |
| 9 | 22743675 | Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. | Eur Respir J | 2012 | https://conductscience.org/library/papers/22743675 | PubMed |
| 10 | 37348121 | Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook. | Am J Respir Crit Care Med | 2023 | https://conductscience.org/library/papers/37348121 | PubMed |
| 11 | 30214187 | Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. | Int J Chron Obstruct Pulmon Dis | 2018 | https://conductscience.org/library/papers/30214187 | PubMed |
| 12 | 38146507 | The Relationship of Fractional Exhaled Nitric Oxide in Patients with AECOPD. | Int J Chron Obstruct Pulmon Dis | 2023 | https://conductscience.org/library/papers/38146507 | PubMed |
| 13 | 27556234 | Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations. | Am J Respir Crit Care Med | 2017 | https://conductscience.org/library/papers/27556234 | PubMed |
| 14 | 37443504 | Use of fractional exhaled nitric oxide as a potential predictor of bronchodilator response. | Medicine (Baltimore) | 2023 | https://conductscience.org/library/papers/37443504 | PubMed |
| 15 | 29609049 | Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma. | J Allergy Clin Immunol Pract | 2018 | https://conductscience.org/library/papers/29609049 | PubMed |
| 16 | 34181876 | Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. | Lancet Respir Med | 2021 | https://conductscience.org/library/papers/34181876 | PubMed |
| 17 | 37189529 | Update on the Role of FeNO in Asthma Management. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37189529 | PubMed |
| 18 | 32642125 | Correlation between fractional exhaled nitric oxide and Asthma Control Test score and spirometry parameters in on-treatment-asthmatics in Ho Chi Minh City. | J Thorac Dis | 2020 | https://conductscience.org/library/papers/32642125 | PubMed |
| 19 | 34772390 | Distribution of inflammatory phenotypes among patients with asthma in Jilin Province, China: a cross-sectional study. | BMC Pulm Med | 2021 | https://conductscience.org/library/papers/34772390 | PubMed |
| 20 | 35812996 | Diagnostic accuracy of FeNO in asthma and predictive value for inhaled corticosteroid responsiveness: A prospective, multicentre study. | EClinicalMedicine | 2022 | https://conductscience.org/library/papers/35812996 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41377008
GET https://conductscience.org/api/papers/v1/41377008/references?page=2